Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFWM
2101
DELISTED
First Foundation Inc
FFWM
| $234K | ﹤0.01% |
16,342
-19,552
| -54% | -$303K |
|
2102
Pilgrim's Pride
PPC
$6.63B
| $234K | ﹤0.01% |
9,868
| – | – |
|
2103
CTS Corp
CTS
$1.77B
| $234K | ﹤0.01% |
5,927
| – | – |
|
2104
Apogee Enterprises
APOG
$822M
| $234K | ﹤0.01% |
5,256
+1
| +0% | +$45 |
|
2105
Pediatrix Medical
MD
$2.15B
| $234K | ﹤0.01% |
15,709
-15,709
| -50% | -$256K |
|
2106
Merchants Bancorp
MBIN
$2.53B
| $233K | ﹤0.01% |
9,602
-12,054
| -56% | -$293K |
|
2107
Nelnet
NNI
$4.83B
| $233K | ﹤0.01% |
2,573
| – | – |
|
2108
Appian
APPN
$1.96B
| $233K | ﹤0.01% |
7,157
| – | – |
|
2109
Levi Strauss
LEVI
$9.44B
| $233K | ﹤0.01% |
15,003
-15,005
| -50% | -$233K |
|
2110
Capitol Federal Financial
CFFN
$1.08B
| $232K | ﹤0.01% |
26,770
-26,774
| -50% | -$221K |
|
2111
Tennant Co
TNC
$1.43B
| $231K | ﹤0.01% |
3,756
| – | – |
|
|
PDM
2112
Piedmont Realty Trust
PDM
$1.23B
| $231K | ﹤0.01% |
25,170
-25,174
| -50% | -$249K |
|
2113
Global Net Lease
GNL
$1.84B
| $230K | ﹤0.01% |
18,294
-18,296
| -50% | -$227K |
|
2114
Liberty Latin America Class C
LILAK
$1.6B
| $230K | ﹤0.01% |
33,314
-33,313
| -50% | -$228K |
|
2115
Revolution Medicines
RVMD
$39.9B
| $229K | ﹤0.01% |
+9,616
| New | +$204K |
|
2116
Southside Bancshares
SBSI
$954M
| $229K | ﹤0.01% |
6,354
| – | – |
|
2117
Comstock Resources
CRK
$3.73B
| $227K | ﹤0.01% |
16,586
-16,590
| -50% | -$283K |
|
2118
Alignment Healthcare
ALHC
$3.07B
| $227K | ﹤0.01% |
19,335
-19,335
| -50% | -$235K |
|
2119
Chefs' Warehouse
CHEF
$4.53B
| $227K | ﹤0.01% |
+6,819
| New | +$237K |
|
2120
Mativ Holdings
MATV
$464M
| $227K | ﹤0.01% |
10,858
-10,858
| -50% | -$235K |
|
2121
TechTarget
TTGT
$320M
| $227K | ﹤0.01% |
5,149
| – | – |
|
|
SHOE
2122
Shoe Station Group
SHOE
$416M
| $226K | ﹤0.01% |
9,458
-194
| -2% | -$4.64K |
|
2123
Preferred Bank
PFBC
$1.22B
| $226K | ﹤0.01% |
+3,027
| New | +$221K |
|
2124
Seaboard Corp
SEB
$4.29B
| $226K | ﹤0.01% |
60
+1
| +2% | +$3.77K |
|
|
BRKL
2125
DELISTED
Brookline Bancorp
BRKL
| $224K | ﹤0.01% |
15,856
-15,856
| -50% | -$212K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.